Parameter
| Biomarker | A. muciniphila | Full name | Akkermansia muciniphila | Molecular Type | microbial |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Research phase and intervention targets |
| Disease | Metabolic Syndrome | Disease Subtypes | / | ||
| Organ | Gut | Test Sample / Technology Platform | Feces (16S rRNA sequencing, qPCR) | ||
| Pathobiological Mechanisms | Degradation of mucous layer, regulate the intestinal barrier and metabolic steady-state, abundance lower associated with MetS | ||||
| Clinical Availability Status | Research phase: Potential probiotic target that improves insulin resistance when supplemented | ||||
| Notes and Dynamics | With Faecalibacterium prausnitzii joint effects can promote flora | ||||